Bariatric Surgery and Fatty Liver Disease

CompletedOBSERVATIONAL
Enrollment

72

Participants

Timeline

Start Date

January 12, 2016

Primary Completion Date

December 16, 2018

Study Completion Date

December 16, 2019

Conditions
Morbid ObesityDiabetesHypertension
Interventions
DIAGNOSTIC_TEST

Biochemistry analysis

Biochemistry analysis of liver parameters were analyzed among the study subjects before and after the surgery.

DIAGNOSTIC_TEST

NAFLD fibrosis score

NAFLD fibrosis score was determined among the study subjects before and after the surgery.

OTHER

BMI measurement

BMI was measured among the study subjects before and after the surgery.

DIAGNOSTIC_TEST

Fibrosis 4 Index

Fibrosis 4 Index was determined among the study subjects before and after the surgery.

DIAGNOSTIC_TEST

Fatty Liver Index

Fatty Liver Index was determined among the study subjects before and after the surgery.

Trial Locations (1)

70852

University Hospital Ostrava, Ostrava

All Listed Sponsors
collaborator

University of Ostrava

OTHER

lead

University Hospital Ostrava

OTHER

NCT04569396 - Bariatric Surgery and Fatty Liver Disease | Biotech Hunter | Biotech Hunter